Does thrombophilia play arm aetiological role in Legg-Calve-Perthes disease?

被引:44
作者
Hayek, S
Kenet, G
Lubetsky, A
Rosenberg, N
Gitel, S
Wientroub, S
机构
[1] Dana Childrens Hosp, Dept Paediat Orthoped, IL-64239 Tel Aviv, Israel
[2] Chaim Sheba Med Ctr, Natl Hemophilia Ctr, Clin Thrombosis Lab, IL-52621 Tel Hashomer, Israel
[3] Chaim Sheba Med Ctr, Inst Thrombosis & Haemostasis, IL-52621 Tel Hashomer, Israel
[4] Chaim Sheba Med Ctr, Mol Biol Res Lab, IL-52621 Tel Hashomer, Israel
[5] Chaim Sheba Med Ctr, Serv Paediat Coagulat, IL-52621 Tel Hashomer, Israel
来源
JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME | 1999年 / 81B卷 / 04期
关键词
D O I
10.1302/0301-620X.81B4.9378
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Heritable thrombophilic disorders have been proposed as one of the causes for Legg-Calve-Perthes disease. A total of 62 patients diagnosed with this disease between 1988 and 1997 and 50 controls were screened for thrombophilia. The incidence and relationship of thrombophilia to the severity of the disease were evaluated. One patient and none of the controls had protein S deficiency. One of the control group and one of the patients had protein C deficiency with the latter child also having a combined deficiency with a mutant factor V gene. The number of children with a mutant factor V gene, protein C deficiency, who were homozygous for the C 677T polymorphism of methylenetetra-hydrofolate reductase or were heterozygous for mutant G20210A prothrombin did not differ statistically in the study and the control groups. No patient had antithrombin deficiency or positive lupus anticoagulant. We found no correlation between thrombophilia and the extent of the disease. The most common risk factors for arteriovenous thromboembolism showed no statistical significance in our patients compared with the control group or with the general population. These data do not confirm an aetiological role for thrombophilia in Perthes' disease.
引用
收藏
页码:686 / 690
页数:5
相关论文
共 32 条
[1]   MATURATION OF THE HEMOSTATIC SYSTEM DURING CHILDHOOD [J].
ANDREW, M ;
VEGH, P ;
JOHNSTON, M ;
BOWKER, J ;
OFOSU, F ;
MITCHELL, L .
BLOOD, 1992, 80 (08) :1998-2005
[2]  
Arruda V. R., 1997, Blood, V90, p110B
[3]   MUTATION IN BLOOD-COAGULATION FACTOR-V ASSOCIATED WITH RESISTANCE TO ACTIVATED PROTEIN-C [J].
BERTINA, RM ;
KOELEMAN, BPC ;
KOSTER, T ;
ROSENDAAL, FR ;
DIRVEN, RJ ;
DERONDE, H ;
VANDERVELDEN, PA ;
REITSMA, PH .
NATURE, 1994, 369 (6475) :64-67
[4]  
CATTERALL A, 1971, Journal of Bone and Joint Surgery British Volume, V53, P37
[5]   PHYSIOLOGICAL ANTICOAGULATION - RESISTANCE TO ACTIVATED PROTEIN-C AND VENOUS THROMBOEMBOLISM [J].
DAHLBACK, B .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 94 (03) :923-927
[6]   Inherited thrombophilia: Pathogenesis, clinical syndromes, and management [J].
DeStefano, V ;
Finazzi, G ;
Mannucci, PM .
BLOOD, 1996, 87 (09) :3531-3544
[7]  
DILLEY A, 1997, THROMB HAEMOS S JUN, P23
[8]   HIGH PREVALENCE OF HYPERHOMOCYST(E)INEMIA IN PATIENTS WITH JUVENILE VENOUS THROMBOSIS [J].
FALCON, CR ;
CATTANEO, M ;
PANZERI, D ;
MARTINELLI, I ;
MANNUCCI, PM .
ARTERIOSCLEROSIS AND THROMBOSIS, 1994, 14 (07) :1080-1083
[9]   A CANDIDATE GENETIC RISK FACTOR FOR VASCULAR-DISEASE - A COMMON MUTATION IN METHYLENETETRAHYDROFOLATE REDUCTASE [J].
FROSST, P ;
BLOM, HJ ;
MILOS, R ;
GOYETTE, P ;
SHEPPARD, CA ;
MATTHEWS, RG ;
BOERS, GJH ;
DENHEIJER, M ;
KLUIJTMANS, LAJ ;
VANDENHEUVEL, LP ;
ROZEN, R .
NATURE GENETICS, 1995, 10 (01) :111-113
[10]  
GALLISTL S, 1997, THROMB HAEMO S JUN, P728